The Flagship Pioneering spinout uses permanent bonds to target shallow pockets, drastically expanding the druggable universe for small molecules.

Attaching amino acids to a hydrophobic organic molecule allows them to self-assemble into rare, knotted structures with ...

I'll take the H2O and Flora 5, thank you ...

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...

Defining precisely where drugs engage their targets in vivo is essential for understanding efficacy and toxicity. However, mapping in vivo drug targets with spatial and cellular resolution remains ...

UCLA chemists proved that some of chemistry’s oldest rules can be broken—and new molecules emerge when they are.

It is not easy to follow the interactions of large molecules with water in real time. But this can be easier to hear than to ...

Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth-quarter of 2025 and provided 2026 financial guidance.

Through a combination of high-pressure experiments and optical spectroscopy, physicists have revealed new insights into the ...

Terremoto Biosciences is a company making waves in the drug development world. They’re using a pretty cool approach to create new medicines, focusing on how molecules interact at a chemical level.